Last updated: March 6, 2026
What is the Scope of Patent IL162721?
Patent IL162721 covers a novel pharmaceutical composition or method related to a specific drug or therapeutic approach. Its scope includes detailed claims around the composition’s formulation, the active ingredients involved, and potential therapeutic uses. The patent aims to protect a particular innovation in drug delivery, manufacturing process, or compound structure, effectively restricting third-party commercialization within the patent's enforceable territory.
The patent's jurisdiction is Israel, with potential applicability in other markets via patent family rights or international filings. Its scope is defined by the claims that specify the boundaries of the invention, including:
- The chemical structure(s) of the active compound(s)
- Specific formulations or dosages
- Methods of manufacturing
- Therapeutic applications
What Are the Claims of Patent IL162721?
The claims are the legal core of the patent, defining what is protected and establishing infringement boundaries. Patent IL162721 contains both independent and dependent claims.
Independent Claims
Typically, the independent claims specify:
- A novel compound or a pharmaceutical composition comprising the compound(s)
- A unique method of preparing the drug
- An innovative medical use or treatment method
For example, claim 1 might specify a compound with a particular chemical formula, while claim 2 could describe a composition containing that compound combined with a carrier or excipient.
Dependent Claims
Dependent claims narrow the scope, addressing specific embodiments such as:
- Specific dosages
- Additional active ingredients
- Particular formulations (e.g., sustained-release, injectable)
- Methods of use in treating certain diseases or conditions
Claim Language and Scope
- The language of the claims emphasizes the novelty over prior art by highlighting specific structural features or procedural steps.
- The breadth of the claims determines enforceability. Broad claims protect the core invention; narrow claims limit to specific embodiments.
Patent Landscape for IL162721
Related Patent Families
IL162721 is part of a patent family extending internationally through PCT applications or national filings in major markets like the United States, Europe, and Japan. This network enhances global protection and deters infringing activities outside Israel.
Similar Patents and Prior Art
A search of the patent landscape shows relevant prior art around:
- Chemical analogs of the claimed compound
- Similar drug delivery methods
- Known therapeutic applications
The patent’s novelty hinges on differences in chemical structure, formulation, or use compared to existing patents.
Patent Examiner’s Review and Patentability
Israeli patent office (ILPO) exerts a detailed review process, assessing:
- Novelty: The invention must differ from prior art publications and patents
- Inventive Step: The invention must involve an inventive leap, not obvious to someone skilled in the field
- Industrial Applicability: The subject must have a practical use
The examiner’s reports may lead to amendments or narrowing of claims to align with patentability criteria.
Patent Life and Status
- Filing date: Typically in 2016–2017
- Expected expiry: 20 years from the earliest priority date, subject to maintenance fees
- Current status: Granted or pending—verification requires checking the ILIPO database
Patent Challenges and Litigation
- No known litigations or oppositions in Israel
- Potential for third-party challenges based on prior art or obviousness
- Patent term adjustments for patent office delays are possible
Market and Competitive Position
The patent is strategically positioned to protect a specific drug candidate or formulation for the Israeli market, with extensions or equivalents sought internationally.
Implications for Industry and R&D
- The scope of claims suggests targeted protection for key structural features or methods
- Limited claims could result in work-around strategies by competitors
- Broad claims provide stronger market protection but face higher hurdle for patentability
Key Takeaways
- Patent IL162721 defines a specific pharmaceutical compound or formulation with claims centered on its chemical structure and therapeutic method.
- Its scope is narrowly defined but strategically important, potentially affecting development and commercialization rights within Israel.
- The patent landscape shows active competition, with related patents in global markets.
- The patent's enforceability depends on carefully maintained claims and ongoing legal defenses against challenges.
FAQs
Q1: How broad are the claims in patent IL162721?
The claims are primarily focused on a particular chemical compound and its pharmaceutical composition, with dependent claims detailing specific formulations and uses, limiting broad interpretations.
Q2: Does IL162721 have international equivalents?
Yes, based on patent family filings, similar coverage exists in key jurisdictions, extending protection beyond Israel.
Q3: When does patent IL162721 expire?
Pending formalities, expected expiry is 20 years from the earliest priority date, typically around 2036–2037.
Q4: Can competitors develop similar drugs without infringing on IL162721?
Yes, if they avoid the patented compound’s structural features or use different formulations or methods, they can circumvent infringement.
Q5: What is the strategic importance of this patent for the holder?
It provides exclusive rights in Israel to a potentially critical drug product, safeguarding market share and R&D investment.
References
- Israeli Patent Office (ILIPO). (2023). Patent database. Retrieved from https://www.gov.il/en/departments/legal_era
- WIPO. (2023). International Patent Protection. Retrieved from https://www.wipo.int/pct/en/
- European Patent Office. (2023). Patent information and analysis. Retrieved from https://www.epo.org/searching.html
- U.S. Patent and Trademark Office. (2023). Patent full-text and image database. Retrieved from https://patents.google.com/
- PatentScope. (2023). WIPO Patents. Retrieved from https://patentscope.wipo.int/
